Private Label Antifungal Barrier Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Private Label Antifungal Barrier Cream
Generic name
MICONAZOLE NITRATE ANTIFUNGAL CREAM
Manufacturer
Swiss-American CDMO, LLC
Product type
HUMAN OTC DRUG
SPL set ID
2ee40c37-504b-43ed-960a-535015407492
SPL ID
05322d7d-55e0-47ae-aa76-58f346e44c4e
Version
1
Effective date
2025-05-09
Source export date
2026-09-28
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:04:47
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Not intended for ingestion. Do not use on children under 2 year of age unless directed by a doctor. Avoid contact with the eyes. For the treatment of athlete’s foot and ringworm. If irritation occurs or if there is no improvement within 4 weeks, discontinue use and consult a doctor. For the prevention of athlete’s foot: if irritation occurs, discontinue use and consult a doctor. Do not use for diaper rash. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.